June 20, 2023 — Today, the U.S. Food and Drug Administration approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and exercise to improve blood sugar control in children 10 years and older…Original Article
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
